Agilent Technologies, Inc. (BVMF:A1GI34)

Market Cap	168.57B -13.7%
Revenue (ttm)	37.01B +8.1%
Net Income	6.76B +2.5%
EPS	23.73 +3.9%
Shares Out	n/a
PE Ratio	24.95
Forward PE	19.02
Dividend	1.81 (0.61%)
Ex-Dividend Date	Mar 30, 2026

Volume	21
Average Volume	4
Open	299.55
Previous Close	300.28
Day's Range	298.41 - 299.55
52-Week Range	290.96 - 410.72
Beta	1.31
RSI	35.00
Earnings Date	May 26, 2026

About Agilent Technologies

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnosti...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1999
• Employees: 18,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: A1GI34

Financial Performance

In fiscal year 2025, Agilent Technologies's revenue was $6.95 billion, an increase of 6.73% compared to the previous year's $6.51 billion. Earnings were $1.30 billion, an increase of 1.09%.

Financial numbers in USD